APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circulating Biomarker

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Circulating Biomarker Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchCirculating Biomarker Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Circulating Biomarker Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Circulating Biomarker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circulating Biomarker Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Circulating Biomarker Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Circulating Biomarker market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Circulating Biomarker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Circulating Biomarker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Circulating Biomarker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Circulating Biomarker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Circulating Biomarker include GE Healthcare, Fluxion Biosciences, Epigenomics AG, Biocept, Becton, Dickinson and Company, Agilent Technologies, Affymetrix and Abbott Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Circulating Biomarker, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Circulating Biomarker, also provides the sales of main regions and countries. Of the upcoming market potential for Circulating Biomarker, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Circulating Biomarker sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Circulating Biomarker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Circulating Biomarker sales, projected growth trends, production technology, application and end-user industry.

Circulating Biomarker Segment by Company

GE Healthcare

Fluxion Biosciences

Epigenomics AG

Biocept

Becton, Dickinson and Company

Agilent Technologies

Affymetrix

Abbott Laboratories

Circulating Biomarker Segment by Type

Circulating DNA

Circulating Tumor Cells

Other

Circulating Biomarker Segment by Application

Early Cancer Screening

Therapy Selection

Treatment Monitoring

Recurrence Monitoring Orthopedics

Circulating Biomarker Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Biomarker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circulating Biomarker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Biomarker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Circulating Biomarker in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circulating Biomarker sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Circulating Biomarker Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Circulating DNA Major Manufacturers Table 3. Circulating Tumor Cells Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Circulating Biomarker Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Early Cancer Screening Major Manufacturers Table 7. Therapy Selection Major Manufacturers Table 8. Treatment Monitoring Major Manufacturers Table 9. Recurrence Monitoring Orthopedics Major Manufacturers Table 10. Circulating Biomarker Industry Trends Table 11. Circulating Biomarker Industry Drivers Table 12. Circulating Biomarker Industry Opportunities and Challenges Table 13. Circulating Biomarker Industry Restraints Table 14. Global Circulating Biomarker Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Circulating Biomarker Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Circulating Biomarker Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Circulating Biomarker Revenue Market Share by Region (2021-2026) Table 18. Global Circulating Biomarker Revenue Market Share by Region (2027-2032) Table 19. Global Circulating Biomarker Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Circulating Biomarker Sales by Region (2021-2026) & (k units) Table 21. Global Circulating Biomarker Sales by Region (2027-2032) & (k units) Table 22. Global Circulating Biomarker Sales Market Share by Region (2021-2026) Table 23. Global Circulating Biomarker Sales Market Share by Region (2027-2032) Table 24. Global Circulating Biomarker Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Circulating Biomarker Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Circulating Biomarker Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Circulating Biomarker Sales Market Share by Manufacturers (2021-2026) Table 28. Global Circulating Biomarker Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Circulating Biomarker Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Circulating Biomarker Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Circulating Biomarker Manufacturers, Product Type & Application Table 32. Global Circulating Biomarker Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Circulating Biomarker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Circulating Biomarker Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Circulating Biomarker Revenue Market Share by Type (2021-2026) Table 39. Global Circulating Biomarker Revenue Market Share by Type (2027-2032) Table 40. Global Circulating Biomarker Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 42. Global Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 43. Global Circulating Biomarker Sales Market Share by Type (2021-2026) Table 44. Global Circulating Biomarker Sales Market Share by Type (2027-2032) Table 45. Global Circulating Biomarker Price by Type (2021-2026) & (US$/unit) Table 46. Global Circulating Biomarker Price by Type (2027-2032) & (US$/unit) Table 47. Global Circulating Biomarker Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Circulating Biomarker Revenue Market Share by Application (2021-2026) Table 51. Global Circulating Biomarker Revenue Market Share by Application (2027-2032) Table 52. Global Circulating Biomarker Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 54. Global Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 55. Global Circulating Biomarker Sales Market Share by Application (2021-2026) Table 56. Global Circulating Biomarker Sales Market Share by Application (2027-2032) Table 57. Global Circulating Biomarker Price by Application (2021-2026) & (US$/unit) Table 58. Global Circulating Biomarker Price by Application (2027-2032) & (US$/unit) Table 59. GE Healthcare Company Information Table 60. GE Healthcare Business Overview Table 61. GE Healthcare Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. GE Healthcare Circulating Biomarker Product Portfolio Table 63. GE Healthcare Recent Development Table 64. Fluxion Biosciences Company Information Table 65. Fluxion Biosciences Business Overview Table 66. Fluxion Biosciences Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Fluxion Biosciences Circulating Biomarker Product Portfolio Table 68. Fluxion Biosciences Recent Development Table 69. Epigenomics AG Company Information Table 70. Epigenomics AG Business Overview Table 71. Epigenomics AG Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Epigenomics AG Circulating Biomarker Product Portfolio Table 73. Epigenomics AG Recent Development Table 74. Biocept Company Information Table 75. Biocept Business Overview Table 76. Biocept Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Biocept Circulating Biomarker Product Portfolio Table 78. Biocept Recent Development Table 79. Becton, Dickinson and Company Company Information Table 80. Becton, Dickinson and Company Business Overview Table 81. Becton, Dickinson and Company Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Becton, Dickinson and Company Circulating Biomarker Product Portfolio Table 83. Becton, Dickinson and Company Recent Development Table 84. Agilent Technologies Company Information Table 85. Agilent Technologies Business Overview Table 86. Agilent Technologies Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Agilent Technologies Circulating Biomarker Product Portfolio Table 88. Agilent Technologies Recent Development Table 89. Affymetrix Company Information Table 90. Affymetrix Business Overview Table 91. Affymetrix Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Affymetrix Circulating Biomarker Product Portfolio Table 93. Affymetrix Recent Development Table 94. Abbott Laboratories Company Information Table 95. Abbott Laboratories Business Overview Table 96. Abbott Laboratories Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Abbott Laboratories Circulating Biomarker Product Portfolio Table 98. Abbott Laboratories Recent Development Table 99. North America Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 102. North America Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 103. North America Circulating Biomarker Sales Price by Type (2021-2026) & (US$/unit) Table 104. North America Circulating Biomarker Sales Price by Type (2027-2032) & (US$/unit) Table 105. North America Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 108. North America Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 109. North America Circulating Biomarker Sales Price by Application (2021-2026) & (US$/unit) Table 110. North America Circulating Biomarker Sales Price by Application (2027-2032) & (US$/unit) Table 111. North America Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Circulating Biomarker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Circulating Biomarker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 115. North America Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 116. North America Circulating Biomarker Sales by Country (2027-2032) & (k units) Table 117. North America Circulating Biomarker Sales Price by Country (2021-2026) & (US$/unit) Table 118. North America Circulating Biomarker Sales Price by Country (2027-2032) & (US$/unit) Table 119. United States Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 120. Canada Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 121. Mexico Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 122. Europe Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 125. Europe Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 126. Europe Circulating Biomarker Sales Price by Type (2021-2026) & (US$/unit) Table 127. Europe Circulating Biomarker Sales Price by Type (2027-2032) & (US$/unit) Table 128. Europe Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 131. Europe Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 132. Europe Circulating Biomarker Sales Price by Application (2021-2026) & (US$/unit) Table 133. Europe Circulating Biomarker Sales Price by Application (2027-2032) & (US$/unit) Table 134. Europe Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Circulating Biomarker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Circulating Biomarker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 138. Europe Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 139. Europe Circulating Biomarker Sales by Country (2027-2032) & (k units) Table 140. Europe Circulating Biomarker Sales Price by Country (2021-2026) & (US$/unit) Table 141. Europe Circulating Biomarker Sales Price by Country (2027-2032) & (US$/unit) Table 142. Germany Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 143. France Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 144. U.K. Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 145. Italy Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 146. Russia Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 147. Spain Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 149. Switzerland Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 150. Sweden Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 151. Poland Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 152. China Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 153. China Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 154. China Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 155. China Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 156. China Circulating Biomarker Sales Price by Type (2021-2026) & (US$/unit) Table 157. China Circulating Biomarker Sales Price by Type (2027-2032) & (US$/unit) Table 158. China Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 159. China Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 160. China Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 161. China Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 162. China Circulating Biomarker Sales Price by Application (2021-2026) & (US$/unit) Table 163. China Circulating Biomarker Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 167. Asia Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 168. Asia Circulating Biomarker Sales Price by Type (2021-2026) & (US$/unit) Table 169. Asia Circulating Biomarker Sales Price by Type (2027-2032) & (US$/unit) Table 170. Asia Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 173. Asia Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 174. Asia Circulating Biomarker Sales Price by Application (2021-2026) & (US$/unit) Table 175. Asia Circulating Biomarker Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Circulating Biomarker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Circulating Biomarker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 180. Asia Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 181. Asia Circulating Biomarker Sales by Country (2027-2032) & (k units) Table 182. Asia Circulating Biomarker Sales Price by Country (2021-2026) & (US$/unit) Table 183. Asia Circulating Biomarker Sales Price by Country (2027-2032) & (US$/unit) Table 184. Japan Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 185. South Korea Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 186. India Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 187. Australia Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 188. Taiwan Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Circulating Biomarker Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Circulating Biomarker Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 193. SAMEA Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 194. SAMEA Circulating Biomarker Sales Price by Type (2021-2026) & (US$/unit) Table 195. SAMEA Circulating Biomarker Sales Price by Type (2027-2032) & (US$/unit) Table 196. SAMEA Circulating Biomarker Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Circulating Biomarker Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 199. SAMEA Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 200. SAMEA Circulating Biomarker Sales Price by Application (2021-2026) & (US$/unit) Table 201. SAMEA Circulating Biomarker Sales Price by Application (2027-2032) & (US$/unit) Table 202. SAMEA Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Circulating Biomarker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Circulating Biomarker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 206. SAMEA Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 207. SAMEA Circulating Biomarker Sales by Country (2027-2032) & (k units) Table 208. SAMEA Circulating Biomarker Sales Price by Country (2021-2026) & (US$/unit) Table 209. SAMEA Circulating Biomarker Sales Price by Country (2027-2032) & (US$/unit) Table 210. Brazil Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 211. Argentina Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 212. Chile Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 213. Colombia Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 214. Peru Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 216. Israel Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 217. UAE Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 218. Turkey Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 219. Iran Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 220. Egypt Circulating Biomarker Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Circulating Biomarker Distributors List Table 224. Circulating Biomarker Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Circulating Biomarker Image Figure 2. Global Circulating Biomarker Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Circulating Biomarker Market Size Share 2021 VS 2025 VS 2032 Figure 4. Circulating DNA Image Figure 5. Circulating Tumor Cells Image Figure 6. Other Image Figure 7. Global Circulating Biomarker Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Circulating Biomarker Market Size Share 2021 VS 2025 VS 2032 Figure 9. Early Cancer Screening Image Figure 10. Therapy Selection Image Figure 11. Treatment Monitoring Image Figure 12. Recurrence Monitoring Orthopedics Image Figure 13. Global Circulating Biomarker Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Circulating Biomarker Revenue (2021-2032) & (US$ Million) Figure 15. Global Circulating Biomarker Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Circulating Biomarker Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Circulating Biomarker Revenue Market Share by Region (2021-2032) Figure 18. Global Circulating Biomarker Sales (2021-2032) & (k units) Figure 19. Global Circulating Biomarker Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Circulating Biomarker Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Circulating Biomarker Sales YoY (2021-2032) & (k units) Figure 22. Europe Circulating Biomarker Sales YoY (2021-2032) & (k units) Figure 23. China Circulating Biomarker Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Circulating Biomarker Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Circulating Biomarker Sales YoY (2021-2032) & (k units) Figure 26. Global Circulating Biomarker Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Circulating Biomarker Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Circulating Biomarker Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Circulating Biomarker Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Circulating Biomarker Revenue Market Share by Type (2021-2032) Figure 32. Global Circulating Biomarker Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Circulating Biomarker Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Circulating Biomarker Sales Market Share by Type (2021-2032) Figure 35. Global Circulating Biomarker Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Circulating Biomarker Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Circulating Biomarker Revenue Market Share by Application (2021-2032) Figure 38. Global Circulating Biomarker Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Circulating Biomarker Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Circulating Biomarker Sales Market Share by Application (2021-2032) Figure 41. North America Circulating Biomarker Revenue Share by Type (2021-2032) Figure 42. North America Circulating Biomarker Sales Share by Type (2021-2032) Figure 43. North America Circulating Biomarker Revenue Share by Application (2021-2032) Figure 44. North America Circulating Biomarker Sales Share by Application (2021-2032) Figure 45. North America Circulating Biomarker Revenue Share by Country (2021-2032) Figure 46. North America Circulating Biomarker Sales Share by Country (2021-2032) Figure 47. Europe Circulating Biomarker Revenue Share by Type (2021-2032) Figure 48. Europe Circulating Biomarker Sales Share by Type (2021-2032) Figure 49. Europe Circulating Biomarker Revenue Share by Application (2021-2032) Figure 50. Europe Circulating Biomarker Sales Share by Application (2021-2032) Figure 51. Europe Circulating Biomarker Revenue Share by Country (2021-2032) Figure 52. Europe Circulating Biomarker Sales Share by Country (2021-2032) Figure 53. China Circulating Biomarker Revenue Share by Type (2021-2032) Figure 54. China Circulating Biomarker Sales Share by Type (2021-2032) Figure 55. China Circulating Biomarker Revenue Share by Application (2021-2032) Figure 56. China Circulating Biomarker Sales Share by Application (2021-2032) Figure 57. Asia Circulating Biomarker Revenue Share by Type (2021-2032) Figure 58. Asia Circulating Biomarker Sales Share by Type (2021-2032) Figure 59. Asia Circulating Biomarker Revenue Share by Application (2021-2032) Figure 60. Asia Circulating Biomarker Sales Share by Application (2021-2032) Figure 61. Asia Circulating Biomarker Revenue Share by Country (2021-2032) Figure 62. Asia Circulating Biomarker Sales Share by Country (2021-2032) Figure 63. SAMEA Circulating Biomarker Revenue Share by Type (2021-2032) Figure 64. SAMEA Circulating Biomarker Sales Share by Type (2021-2032) Figure 65. SAMEA Circulating Biomarker Revenue Share by Application (2021-2032) Figure 66. SAMEA Circulating Biomarker Sales Share by Application (2021-2032) Figure 67. SAMEA Circulating Biomarker Revenue Share by Country (2021-2032) Figure 68. SAMEA Circulating Biomarker Sales Share by Country (2021-2032) Figure 69. Circulating Biomarker Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Circulating Biomarker Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Circulating DNA
  • Circulating Tumor Cells
  • Other
Applications
  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring Orthopedics
Companies covered
  • GE Healthcare
  • Fluxion Biosciences
  • Epigenomics AG
  • Biocept
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Affymetrix
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Circulating Biomarker Market by Type
  3. 1.2.1 Global Circulating Biomarker Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Circulating DNA
  5. 1.2.3 Circulating Tumor Cells
  6. 1.2.4 Other
  7. 1.3 Circulating Biomarker Market by Application
  8. 1.3.1 Global Circulating Biomarker Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Early Cancer Screening
  10. 1.3.3 Therapy Selection
  11. 1.3.4 Treatment Monitoring
  12. 1.3.5 Recurrence Monitoring Orthopedics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Circulating Biomarker Market Dynamics
  1. 2.1 Circulating Biomarker Industry Trends
  2. 2.2 Circulating Biomarker Industry Drivers
  3. 2.3 Circulating Biomarker Industry Opportunities and Challenges
  4. 2.4 Circulating Biomarker Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Circulating Biomarker Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Circulating Biomarker Revenue by Region
  3. 3.2.1 Global Circulating Biomarker Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Circulating Biomarker Revenue by Region (2021-2026)
  5. 3.2.3 Global Circulating Biomarker Revenue by Region (2027-2032)
  6. 3.2.4 Global Circulating Biomarker Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Circulating Biomarker Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Circulating Biomarker Sales by Region
  9. 3.4.1 Global Circulating Biomarker Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Circulating Biomarker Sales by Region (2021-2026)
  11. 3.4.3 Global Circulating Biomarker Sales by Region (2027-2032)
  12. 3.4.4 Global Circulating Biomarker Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Circulating Biomarker Revenue by Manufacturers
  2. 4.1.1 Global Circulating Biomarker Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Circulating Biomarker Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Circulating Biomarker Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Circulating Biomarker Sales by Manufacturers
  6. 4.2.1 Global Circulating Biomarker Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Circulating Biomarker Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Circulating Biomarker Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Circulating Biomarker Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Circulating Biomarker Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Circulating Biomarker Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Circulating Biomarker Manufacturers, Product Type & Application
  13. 4.7 Global Circulating Biomarker Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Circulating Biomarker Market CR5 and HHI
  16. 4.8.2 2025 Circulating Biomarker Tier 1, Tier 2, and Tier 3
5 Circulating Biomarker Market by Type
  1. 5.1 Global Circulating Biomarker Revenue by Type
  2. 5.1.1 Global Circulating Biomarker Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Circulating Biomarker Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Circulating Biomarker Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Circulating Biomarker Sales by Type
  6. 5.2.1 Global Circulating Biomarker Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Circulating Biomarker Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Circulating Biomarker Sales Market Share by Type (2021-2032)
  9. 5.3 Global Circulating Biomarker Price by Type
6 Circulating Biomarker Market by Application
  1. 6.1 Global Circulating Biomarker Revenue by Application
  2. 6.1.1 Global Circulating Biomarker Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Circulating Biomarker Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Circulating Biomarker Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Circulating Biomarker Sales by Application
  6. 6.2.1 Global Circulating Biomarker Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Circulating Biomarker Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Circulating Biomarker Sales Market Share by Application (2021-2032)
  9. 6.3 Global Circulating Biomarker Price by Application
7 Company Profiles
  1. 7.1 GE Healthcare
  2. 7.1.1 GE Healthcare Company Information
  3. 7.1.2 GE Healthcare Business Overview
  4. 7.1.3 GE Healthcare Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GE Healthcare Circulating Biomarker Product Portfolio
  6. 7.1.5 GE Healthcare Recent Developments
  7. 7.2 Fluxion Biosciences
  8. 7.2.1 Fluxion Biosciences Company Information
  9. 7.2.2 Fluxion Biosciences Business Overview
  10. 7.2.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Fluxion Biosciences Circulating Biomarker Product Portfolio
  12. 7.2.5 Fluxion Biosciences Recent Developments
  13. 7.3 Epigenomics AG
  14. 7.3.1 Epigenomics AG Company Information
  15. 7.3.2 Epigenomics AG Business Overview
  16. 7.3.3 Epigenomics AG Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Epigenomics AG Circulating Biomarker Product Portfolio
  18. 7.3.5 Epigenomics AG Recent Developments
  19. 7.4 Biocept
  20. 7.4.1 Biocept Company Information
  21. 7.4.2 Biocept Business Overview
  22. 7.4.3 Biocept Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biocept Circulating Biomarker Product Portfolio
  24. 7.4.5 Biocept Recent Developments
  25. 7.5 Becton, Dickinson and Company
  26. 7.5.1 Becton, Dickinson and Company Company Information
  27. 7.5.2 Becton, Dickinson and Company Business Overview
  28. 7.5.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Becton, Dickinson and Company Circulating Biomarker Product Portfolio
  30. 7.5.5 Becton, Dickinson and Company Recent Developments
  31. 7.6 Agilent Technologies
  32. 7.6.1 Agilent Technologies Company Information
  33. 7.6.2 Agilent Technologies Business Overview
  34. 7.6.3 Agilent Technologies Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Agilent Technologies Circulating Biomarker Product Portfolio
  36. 7.6.5 Agilent Technologies Recent Developments
  37. 7.7 Affymetrix
  38. 7.7.1 Affymetrix Company Information
  39. 7.7.2 Affymetrix Business Overview
  40. 7.7.3 Affymetrix Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Affymetrix Circulating Biomarker Product Portfolio
  42. 7.7.5 Affymetrix Recent Developments
  43. 7.8 Abbott Laboratories
  44. 7.8.1 Abbott Laboratories Company Information
  45. 7.8.2 Abbott Laboratories Business Overview
  46. 7.8.3 Abbott Laboratories Circulating Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Abbott Laboratories Circulating Biomarker Product Portfolio
  48. 7.8.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Circulating Biomarker Market Size by Type
  2. 8.1.1 North America Circulating Biomarker Revenue by Type (2021-2032)
  3. 8.1.2 North America Circulating Biomarker Sales by Type (2021-2032)
  4. 8.1.3 North America Circulating Biomarker Price by Type (2021-2032)
  5. 8.2 North America Circulating Biomarker Market Size by Application
  6. 8.2.1 North America Circulating Biomarker Revenue by Application (2021-2032)
  7. 8.2.2 North America Circulating Biomarker Sales by Application (2021-2032)
  8. 8.2.3 North America Circulating Biomarker Price by Application (2021-2032)
  9. 8.3 North America Circulating Biomarker Market Size by Country
  10. 8.3.1 North America Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Circulating Biomarker Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Circulating Biomarker Market Size by Type
  2. 9.1.1 Europe Circulating Biomarker Revenue by Type (2021-2032)
  3. 9.1.2 Europe Circulating Biomarker Sales by Type (2021-2032)
  4. 9.1.3 Europe Circulating Biomarker Price by Type (2021-2032)
  5. 9.2 Europe Circulating Biomarker Market Size by Application
  6. 9.2.1 Europe Circulating Biomarker Revenue by Application (2021-2032)
  7. 9.2.2 Europe Circulating Biomarker Sales by Application (2021-2032)
  8. 9.2.3 Europe Circulating Biomarker Price by Application (2021-2032)
  9. 9.3 Europe Circulating Biomarker Market Size by Country
  10. 9.3.1 Europe Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Circulating Biomarker Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Circulating Biomarker Market Size by Type
  2. 10.1.1 China Circulating Biomarker Revenue by Type (2021-2032)
  3. 10.1.2 China Circulating Biomarker Sales by Type (2021-2032)
  4. 10.1.3 China Circulating Biomarker Price by Type (2021-2032)
  5. 10.2 China Circulating Biomarker Market Size by Application
  6. 10.2.1 China Circulating Biomarker Revenue by Application (2021-2032)
  7. 10.2.2 China Circulating Biomarker Sales by Application (2021-2032)
  8. 10.2.3 China Circulating Biomarker Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Circulating Biomarker Market Size by Type
  2. 11.1.1 Asia Circulating Biomarker Revenue by Type (2021-2032)
  3. 11.1.2 Asia Circulating Biomarker Sales by Type (2021-2032)
  4. 11.1.3 Asia Circulating Biomarker Price by Type (2021-2032)
  5. 11.2 Asia Circulating Biomarker Market Size by Application
  6. 11.2.1 Asia Circulating Biomarker Revenue by Application (2021-2032)
  7. 11.2.2 Asia Circulating Biomarker Sales by Application (2021-2032)
  8. 11.2.3 Asia Circulating Biomarker Price by Application (2021-2032)
  9. 11.3 Asia Circulating Biomarker Market Size by Country
  10. 11.3.1 Asia Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Circulating Biomarker Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Circulating Biomarker Market Size by Type
  2. 12.1.1 SAMEA Circulating Biomarker Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Circulating Biomarker Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Circulating Biomarker Price by Type (2021-2032)
  5. 12.2 SAMEA Circulating Biomarker Market Size by Application
  6. 12.2.1 SAMEA Circulating Biomarker Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Circulating Biomarker Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Circulating Biomarker Price by Application (2021-2032)
  9. 12.3 SAMEA Circulating Biomarker Market Size by Country
  10. 12.3.1 SAMEA Circulating Biomarker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Circulating Biomarker Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Circulating Biomarker Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Circulating Biomarker Value Chain Analysis
  2. 13.1.1 Circulating Biomarker Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Circulating Biomarker Production Mode & Process
  6. 13.2 Circulating Biomarker Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Circulating Biomarker Distributors
  9. 13.2.3 Circulating Biomarker Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst